Altuzan (Avastin ) 100 MG 4 ML


AVASTIN®, in combination with intravenous 5‑fluorouracil‑based chemotherapy, is indicated for first- or second‑line treatment of patients with metastatic carcinoma of the colon or rectum. Avastin, in combination with carboplatin and paclitaxel, is indicated for first‑line treatment of patients with unresectable, locally advanced, recurrent or metastatic non-squamous, non-small cell lung cancer.


There are no reviews yet.

Be the first to review “Altuzan (Avastin ) 100 MG 4 ML”

Your email address will not be published. Required fields are marked *